Briakinumab Antibody
Briakinumab (ABT-874) is a human monoclonal antibody designed to neutralize interleukin-12 (IL-12) . It has been investigated in preclinical and clinical research for immune-mediated conditions, including psoriasis, inflammatory bowel disease, and multiple sclerosis, through both in vitro and in vivo experimental models.
Product Specifications
Product Name Alternative
J 695, ABT874, ABT-874, A-796874.0, BSF415977, BSF 415977
Target
IL Receptor, Interleukin
Clonality
Monoclonal
Conjugation
Unconjugated
Field of Research
Immunology & Inflammation
Concentration
8.3 mg/mL
Purity
>95% (May vary between batches)
Molecular Weight
143.86 kDa
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNCB2137-500 1x 500 µL
OCT-2 (POU2F2) (B-Cell Marker) (OCT2/2137), Biotin conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
GM-47-40 1 mL
Colloidal Gold Conjugated Monoclonal Antibody to Hepatitis B Surface Antigen, 40nm
Sign In for Pricing
View Details